Niederer Kraft Frey advised Hangzhou GreatStar Industrial on its offering of global depositary receipts (GDRs) and SIX Swiss Exchange listing under the China-Switzerland Stock Connect. Hangzhou GreatStar, whose A Shares are listed on Shenzhen Stock
Tags :Philippe Weber
Niederer Kraft Frey has advised the underwriting syndicate led by Goldman Sachs International and UBS on the offering of global depositary receipts (GDR) and SIX Swiss Exchange listing of Sunwoda Electronic under the China-Switzerland Stock
StoneX Group, a global financial services company, announced that it had acquired Cotton Distributors (CDI). CDI operates a global cotton merchant business and is headquartered in Lausanne with an office in Brazil. Homburger advised StoneX
Niederer Kraft Frey advised the Beijing company Lepu Medical Technology on its successful USD 224 million offering and listing of global depositary receipts on SIX Swiss Exchange within the framework of the China-Switzerland Stock Connect
Baker McKenzie has acted as legal advisor on the successful offering and listings of Global Depositary Receipts (GDR) on SIX Swiss Exchange of four Chinese companies: GEM Co., Gotion High-tech Co., Keda Industrial Group Co.,
FEMSA and Valora join forces in an agreement for the acquisition of Valora Holding by FEMSA. The leading Latin American retailer will acquire Swiss Valora in a cash tender offer. Fomento Económico Mexicano, S.
Niederer Kraft Frey advised Deutsche Bank, acting as coordinator, HSBC acting as agent and further banks on the Revolving Committed Facility of DKSH Holding. DKSH Holding is a SIX Swiss Exchange listed company specializing in
Niederer Kraft Frey acted as legal counsel to the sales enablement platform for enterprise companies Pitcher on a transaction leading to a strategic growth investment from Crest Rock Partners. Founded in 2011 by Mert Yentür,
Niederer Kraft Frey advised EPIC Suisse as issuer’s counsel in connection with its initial public offering and listing on SIX Swiss Exchange. The transaction represents the first traditional IPO on the Main Market of
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
